PDCD1 and lung cancer: Nonetheless, these BTLA+ lymphocytes, which are also PD-1+, TIM3+, CTLA-4+, and LAG-3+, seem to be terminally exhausted and poorly functional, and are associated to disease progression in lung cancer (38).